Clinical Trial Update: High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial investigating high-dose corticosteroids or tocilizumab for clinical worsening in COVID-19 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Virus Infection
• Cytokine Storm

Drugs mentioned

• Corticosteroids (corticosteroids)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Marmara University | Conditions: COVID-19 Virus Infection, Cytokine Storm | Phase 4 | Status: WITHDRAWN